Editorial: Directing myogenic mesenchymal stem cell differentiation

Circulation Research

Volumn 103, Issue 6, 2008, Pages 560-561

  Westerweel, Peter E ^a   Verhaar, Marianne C ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

Mesenchymal stem cells; MRTF; Myocardin; Smooth muscle differentiation; Sphingosylphosphorylcholine; Stem cells

Indexed keywords

SERUM RESPONSE FACTOR; SPHINGOSYLPHOSPHORYLCHOLINE;

ADIPOSE TISSUE; ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; BLOOD VESSEL TONE; BONE MARROW; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL PROLIFERATION; EDITORIAL; HEART MUSCLE ISCHEMIA; HYPERTENSION; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; MUSCLE DEVELOPMENT; NEOVASCULARIZATION (PATHOLOGY); POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN BINDING; SMOOTH MUSCLE FIBER; TISSUE ENGINEERING; VASCULAR SMOOTH MUSCLE; WOUND HEALING; ANIMAL; CYTOLOGY; HUMAN; NOTE; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; HUMANS; MESENCHYMAL STEM CELLS; MUSCLE, SMOOTH, VASCULAR; SIGNAL TRANSDUCTION;

EID: 53249149630     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.108.184374     Document Type: Editorial

References (25)

1. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004;84:767-801.
2. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284: 143-147.
3. Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res. 2007;100:1249-1260.
4. Silva GV, Litovsky S, Assad JA, Sousa AL, Martin BJ, Vela D, Coulter SC, Lin J, Ober J, Vaughn WK, Branco RV, Oliveira EM, He R, Geng YJ, Willerson JT, Perin EC. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation. 2005;111: 150-156.
5. Yoon YS, Wecker A, Heyd L, Park JS, Tkebuchava T, Kusano K, Hanley A, Scadova H, Qin G, Cha DH, Johnson KL, Aikawa R, Asahara T, Losordo DW. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest. 2005;115:326-338.
6. Jeon ES, Park WS, Lee MJ, Kim YM, Han J, Kim JH. A Rho kinase/myocardin-related transcription factor-A-dependent mechanism underlies the sphingosylphosphorylcholine-induced differentiation of mesenchymal stem cells into contractile smooth muscle cells. Circ Res. 2008;103:635-642.
7. Nixon GF, Mathieson FA, Hunter I. The multi-functional role of sphin-gosylphosphorylcholine. Prog Lipid Res. 2008;47:62-75.
8. Kleger A, Busch T, Liebau S, Prelle K, Paschke S, Beil M, Rolletschek A Wobus A, Wolf E, Adler G, Seufferlein T. The bioactive lipid sphingosylphos-phorylcholine induces differentiation of mouse embryonic stem cells and human promyelocytic leukaemia cells. Cell Signal. 2007;19:367-377.
9. Boguslawski G, Lyons D, Harvey KA, Kovala AT, English D. Sphingo-sylphosphorylcholine induces endothelial cell migration and morphogenesis. Biochem Biophys Res Commun. 2000;272:603-609.
10. Li S, Tanaka H, Wang HH, Yoshiyama S, Kumagai H, Nakamura A, Brown DL, Thatcher SE, Wright GL, Kohama K. Intracellular signal transduction for migration and actin remodeling in vascular smooth muscle cells after sphingosylphosphorylcholine stimulation. Am J Physiol Heart Circ Physiol. 2006;291:H1262-H1272.
11. Shirao S, Kashiwagi S, Sato M, Miwa S, Nakao F, Kurokawa T, Todoroki-Ikeda N, Mogami K, Mizukami Y, Kuriyama S, Haze K, Suzuki M, Kobayashi S. Sphingosylphosphorylcholine is a novel messenger for Rho-kinase-mediated Ca2+ sensitization in the bovine cerebral artery: unimportant role for protein kinase C. Circ Res. 2002;91:112-119.
12. Bitar KN, Yamada H. Modulation of smooth muscle contraction by sphingosylphosphorylcholine. Am J Physiol. 1995;269(3 pt 1):G370-G377.
13. Jeon ES, Moon HJ, Lee MJ, Song HY, Kim YM, Bae YC, Jung JS, Kim JH. Sphingosylphosphorylcholine induces differentiation of human mesenchymal stem cells into smooth-muscle-like cells through a TGF-beta-dependent mechanism. J Cell Sci. 2006;119(pt 23):4994-5005.
14. Moon HJ, Jeon ES, Kim YM, Lee MJ, Oh CK, Kim JH. Sphingosylphosphorylcholine stimulates expression of fibronectin through TGF-beta1-Smad-dependent mechanism in human mesenchymal stem cells. Int J Biochem Cell Biol. 2007;39:1224-1234.
15. Kinner B, Zaleskas JM, Spector M. Regulation of smooth muscle actin expression and contraction in adult human mesenchymal stem cells. Exp Cell Res. 2002;278:72-83.
16. Parmacek MS. Myocardin-related transcription factors: critical coactiva-tors regulating cardiovascular development and adaptation. Circ Res. 2007;100:633-644.
17. Chen J, Kitchen CM, Streb JW, Miano JM. Myocardin: a component of a molecular switch for smooth muscle differentiation. JMol Cell Cardiol. 2002;34:1345-1356.
18. Yoshida T, Sinha S, Dandre F, Wamhoff BR, Hoofnagle MH, Kremer BE, Wang DZ, Olson EN, Owens GK. Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes. Circ Res. 2003;92:856-864.
19. Lim JY, Park SI, Oh JH, Kim SM, Jeong CH, Jun JA, Lee KS, Oh W, Lee JK, Jeun SS. Brain-derived neurotrophic factor stimulates the neural differentiation of human umbilical cord blood-derived mesenchymal stem cells and survival of differentiated cells through MAPK/ERK and PI3K/ Akt-dependent signaling pathways. J Neurosci Res. 2008;86:2168-2178.
20. Tamama K, Sen CK, Wells A. Differentiation of bone marrow mesenchymal stem cells into the smooth muscle lineage by blocking ERK/MAPK signaling pathway. Stem Cells Dev. Available ahead of print at: DOI 10.1009/scd.2007.0155.
21. Chamberlain G, Fox J, Ashton B, Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells. 2007;25:2739-2749.
22. Nixon GF, Mathieson FA, Hunter I. The potential roles of sphingolipids in vascular smooth-muscle function. Biochem Soc Trans. 2007;35(pt 5):908-909.
23. Xu Q. Stem cells and transplant arteriosclerosis. Circ Res. 2008;102: 1011-1024.
24. Madonna R, Willerson JT, Geng YJ. Myocardin a enhances telomerase activities in adipose tissue mesenchymal cells and embryonic stem cells undergoing cardiovascular myogenic differentiation. Stem Cells. 2008; 26:202-211.
25. Grauss RW, van TJ, Steendijk P, Winter EM, Pijnappels DA, Hogers B, Gittenberger-De Groot AC, van der GR, van der LA, de Vries AA, Schalij MJ, Atsma DE. Forced myocardin expression enhances the therapeutic effect of human mesenchymal stem cells after transplantation in ischemic mouse hearts. Stem Cells. 2008;26:1083-1093.